Clinical Trials Directory

Trials / Completed

CompletedNCT01204957

Brown Seaweed as a Breast Cancer Preventive

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
33 (actual)
Sponsor
University of South Carolina · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Japanese postmenopausal women in Japan have about one ninth the rate of American postmenopausal women. Rates of breast cancer double even after just ten years among Japanese women who migrate to the US. Diet is thought to be an important factor, and the investigators were interested in whether dietary seaweed, with and without soy supplements, could influence known biomarkers of breast cancer risk in American women.

Detailed description

33 healthy postmenopausal women were randomized to 6 wk seaweed then 1 wk seaweed plus soy or 6 wk placebo then 1 wk placebo plus soy. Blood and urine samples were collected at the end of each treatment period and analyzed for estrogen, homocysteine, antioxidants, insulin-like growth factors and thyroid hormones. Urine was analyzed for phytoestrogens and iodine.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSeaweed and Soy Protein5 g/d Seaweed for 6 wks, followed by 5 g/d Seaweed + Soy Protein for 1 wk
DIETARY_SUPPLEMENTPlacebo and Soy Protein5 g/d Placebo for 6 wks, followed by 5 g/d Placebo + Soy Protein for 1 wk

Timeline

Start date
1998-10-01
Primary completion
1999-03-01
Completion
1999-03-01
First posted
2010-09-17
Last updated
2015-04-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01204957. Inclusion in this directory is not an endorsement.